FDA
label_change
· 2016-11-02
FDA Approved: DIGOXIN — Supplemental Application (Sandoz Inc)
Summary
FDA approved a supplemental application for digoxin from Sandoz Inc, resulting in a label change for the generic heart medication.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DIGOXIN (DIGOXIN)